PolyPid launches combined polymer-lipid delivery tech
PolyPid claims its new polymer-lipid combination delivery tech will let pharmas set precise release characteristics for a variety of small molecule, protein and nucleic acid-base drugs.
The patented technology comprises a lipid-based matrix and a non-biodegradable polymer, in which one or more active pharmaceutical ingredients (API) can be held, can be formulated to release them at a pre-programmed rate for up to several months.
The first PolyPid-based solution is BonyPid, the Israeli firm’s own biodegradable bone void filler; however, the technology is suitable for a wide range of pharmaceutical controlled release delivery applications according to CTO Noam Emanuel.
"Due to its flexibility, the PolyPid platform can be utilized to address numerous medical indications in various fields, such as orthopaedics, urology, periodontal, anti-cancer/anti-fungal treatments and surgical accessories."
